Clinical aspects of pregnancy and childbirth in women with intrahepatic cholestasis of pregnancy
pdf

Keywords

intrahepatic cholestasis of pregnancy
pregnancy
childbirth

How to Cite

CEMORTAN, M., SAGAIDAC, I., ILIADI-TULBURE, C. and CERNETCHI, O. (2024) “Clinical aspects of pregnancy and childbirth in women with intrahepatic cholestasis of pregnancy”, One Health & Risk Management , 5(2), pp. 42-48. doi: 10.38045/ohrm.2024.2.05.

Abstract

Introduction. Intrahepatic cholestasis of pregnancy (ICP) is a liver pathology that has negative impact on progression of pregnancy and childbirth in affected women. This study aims to assess the clinical characteristics of pregnancy and delivery among women diagnosed with intrahepatic cholestasis of pregnancy.

Material and methods. The study was conducted as a prospective cohort study involving 142 clinical cases, divided into two groups according to the complication of pregnancy with cholestasis gravidarum. Evaluation of pregnancy and childbirth clinical aspects was performed alongside an examination of medical records. Statistical data were processed using IBM Statistics SPSS 21, MedCalc and GraphPad software.

Results. It was determined that every fourth pregnant woman diagnosed with intrahepatic cholestasis of pregnancy also presented with hyperemesis gravidarum during the current pregnancy. Additionally, an elevated prevalence of iron deficiency anemia and gestational diabetes mellitus was detected among pregnant women with this condition. Meconium staining of the amniotic fluid complicated approximately one in every four pregnancies in women with intrahepatic cholestasis gravidarum.

Conclusions. The study findings indicate a notable increase in hepato-biliary conditions and nephrourinary pathology among women with ICP. Hence, a high incidence of hyperemesis gravidarum, along with an elevated frequency of iron deficiency anemia and gestational diabetes mellitus, was found in women with this condition.

https://doi.org/10.38045/ohrm.2024.2.05
pdf

|Views: 367| |pdf Downloads: 301|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Maria Cemortan, Irina Sagaidac, Corina Iliadi-Tulbure, Olga Cernetchi

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370